The global demand for Fibrinogen Concentrates Market is presumed to reach the market size of nearly USD 2357.07 MN by 2030 from USD 978.22 MN in 2022 with a CAGR of 11.62% under the study period 2023 - 2030.
Fibrinogen Concentrate is a coagulation factor found in human blood. Fibrinogen concentration is a fibrinogen type used to treat severe bleeding in persons with afibrinogenemia or hypofibrinogenemia, a congenital lack of fibrinogen. It is a glycoprotein found in vertebrates that aids in the production of blood clots and is utilized as a blood disease treatment. Fibrinogen concentrate enhances whole blood clot hardness and minimizes the need for postoperative transfusions in severely bleeding patients. Three enzymes, thrombin, factor XIIIa, and plasmin, use it as a physiological substrate. Fibrinogen concentrates are now commonly employed instead of traditional fibrinogen sources such as fresh frozen plasma and cryoprecipitate.
Market Dynamics
The global market is expected to rise due to an increase in fibrinogen concentrates in bleeding patients and for the treatment of congenital disabilities. Furthermore, the market's expansion is aided by increased public knowledge and worries about health. In addition, the rising prevalence of bleeding diseases and an increase in the number of approvals for fibrinogen concentrate are essential contributors to the market's growth. However, some side effects, such as arterial thrombosis, cold, dyspnea, nausea, vomiting, and pulmonary embolism, limit growth.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of fibrinogen concentrates. The growth and trends of fibrinogen concentrates industry provide a holistic approach to this study.
Market Segmentation
This section of the fibrinogen concentrates market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Type
- Human Fibrinogen Concentrates
- Animal Fibrinogen Concentrates
By Application
- Congenital Fibrinogen Deficiency
- Surgical Procedures
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Fibrinogen Concentrates market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Fibrinogen Concentrates Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the fibrinogen concentrates market include CSL Behring, Baxter International Inc., LFB Group, ProFibrix BV, Shanghai RAAS, Jiangxi Boya Bio-Pharmaceutical, Hualan Biological Engineering, Harbin Pacific Biopharmaceutical Co. Ltd., Green Cross International, and Shanghai Xinxing Medicine Co. Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.